Need Help or want to give your feedback?

Whether you’re having trouble with your account, or would like to make a suggestion, Canadian Blood Services offers you quick and convenient options to troubleshoot or get in touch. Contact us via live chat, consult our FAQ, send an email feedback@blood.ca, or give us a call at 1 888 2 DONATE (1-888-236-6283).

Ni, Heyu

Back To Our Investigators
 

Heyu Ni

Contact Dr. Ni

Mailing Address:

Keenan Research Centre for Biomedical Research
St. Michael's Hospital
209 Victoria Street
Toronto, ON, M5B 1W8
Canada

Phone Number: 416-864-6060
ext. 6758

Phone Number: 416-847-1738
Email: heyu.ni@utoronto.ca
Email: NiH@smh.ca

Other Website
Other Website
PubMed
Google Scholar

Scientist
Centre for Innovation
Canadian Blood Services

Platform Director and Scientist for Hematology, Cancer and Immunological Diseases
Keenan Research Centre for Biomedical Science
St. Michael's Hospital

Professor
Laboratory Medicine and Pathobiology
University of Toronto

Professor
Medicine
University of Toronto

Professor
Physiology
University of Toronto

Hemostasis and Thrombosis - finding the right balance

A complex system of cells, proteins and signaling molecules in the blood and blood vessels maintain a delicate balance between bleeding (hemostasis) and clotting (thrombosis). Dr. Heyu Ni’s laboratory investigates the role(s) of adhesion molecules involved in clot formation and their implications for hemostasis (including bleeding disorders) and thrombotic diseases (including heart attack and stroke).

Why is this important?

Understanding the cellular and molecular mechanisms of hemostasis and thrombotic diseases could lead to the development of new therapies as well as diagnostic tools to control bleeding disorders and cardiovascular diseases, such as heart attack and stroke, which are the leading cause of mortality and morbidity worldwide.

[Read more]

Understanding Diseases to Optimize Transfusion Practice

Dr. Heyu Ni’s laboratory studies allo- and auto-immune diseases related to bleeding disorders such as immune thrombocytopenia (ITP) and fetal and neonatal alloimmune thrombocytopenic purpura (FNAIT). These diseases are characterized by the presence of antibodies that target platelet antigens and result in a loss of platelets, which in turn can lead to uncontrolled bleeding and, in rare cases, death.

Why is this important?

These studies help us understand immune diseases and their treatment and could lead to more appropriate clinical practice of both diagnosis and treatment.

[Read more]

Leadership Roles:

2011 - Current

Council Committee Member, International Society of Thrombosis and Haemostasis

Education:

  • Doctor of Philosophy, University of Manitoba

  • MD, Anhui Medical University, China

  • Master of Science, Anhui Medical University, China